ArticleFrontiers in aging neuroscience2025
Early identification of mild cognitive impairment: an innovative model using ocular biomarkers.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive, irreversible brain damage. Current diagnostic procedures for AD are both costly and highly invasive for patients. Age-related cataract (ARC), a common ocular condition in elderly populations, correlates with a 1.43-fold increased risk of developing AD. This study sought to establish a novel model for early detection of mild cognitive impairment (MCI) in patients with ARC. Methods: The study prospectively collected 170 monocular data as training dataset and 65 monocular data from another independent medical center as test dataset. Demographic data and comprehensive ophthalmic examination results were collected. The least absolute shrinkage and selection operator (LASSO) method and multivariate logistic regression analysis were performed using R software for dimensionality reduction and variable selection. A nomogram was constructed, and its discriminative ability was evaluated using receiver operating characteristic (ROC) curve, area under the ROC curve (AUC) with 95% confidence interval (CI), as well as sensitivity and specificity. Internal validation was performed using 1,000-resample bootstrap analysis, while model calibration was assessed through calibration curves and Brier scores. Decision curve analysis (DCA) was performed to evaluate clinical utility. A baseline model incorporating demographic variables was developed for comparison with the nomogram. Additionally, an external dataset from an independent medical center was employed as a test set to further validate the nomogram's predictive performance. An online calculator was created using the "DynNom" and "rsconnect" functions. Results: Through LASSO regression and multivariate logistic regression analyses, six variables were identified and incorporated into the nomogram: age (OR: 1.097; 95%CI: 1.041-1.161; Conclusion: Through systematic analysis of clinical data, this study established and validated a novel online calculator for identifying early cognitive impairment in patients with ARC, using demographic and ocular biomarkers, thereby providing a visual representation of the prediction model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.